System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Prof Johanne Silvain is an expert in Cardiology at Pitié-Salpêtrière Hospital (France). As of October 2026, ScienceLeadR ranks Johanne Silvain in the top 1% of experts worldwide for Myocardial Ischemia, Coronary Disease and Arteriosclerosis. Johanne Silvain has authored 386 publications, the most recent in 2026, and is an investigator in 40 clinical trials, 6 of them ongoing. SLR score: 2,002 (community average: 125). How the SLR is computed.

LeadR Profile

Prof Johanne Silvain Pitié-Salpêtrière Hospital France
2 002 ScienceLeadR Reputation 2002

Unlock

Register Login
Network Map

Cardiology

Subspecialties: Public Health - Biostatistics - Hematology

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2010 - 2026
Source: PubMed

Pitié-Salpêtrière Hospital

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 386

Citations

Citations: 14 156 1st author: 55 Last author: 29 Unique author: 1

Main journals

Eur Heart J 76
J Am Coll Cardiol 32
Circulation 24
Archives of Cardiovascular Diseases Supplements 21
Arch Cardiovasc Dis 20

Best Journals

Eur Heart J 31
N Engl J Med 12
Circulation 8

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Prevalence, Predictors, and Clinical Implications of Residual Shunt After Patent Foramen Ovale Percutaneous Closure.
PMID 42862913 — foramen ovale, patent, prevalence, blood circulation, foramen ovale		Circulation Top journal20260
Discontinuation of β-blockers in stable patients with previous myocardial infarction, preserved left ventricular ejection fraction, and no heart failure: a pooled analysis of individual patient data.
PMID 42669300 — myocardial infarction, heart failure, heart, therapeutics		Lancet Top journal20262
Prognostic impact of pericardial effusion in patients with acute myocarditis.
PMID 42670209 — pericardial effusion, cardiovascular diseases, phenotype, myocarditis, echocardiography		Eur Heart J Acute Cardiovasc Care20261
LDL Cholesterol Lowering With Evolocumab Before Percutaneous Coronary Intervention for Acute Myocardial Infarction: The AMUNDSEN Randomized Clinical Trial.
PMID 42666092 — cholesterol, ldl, myocardial infarction, percutaneous coronary intervention, cholesterol, odds ratio, therapeutics		JAMA Top journal20262
Biodegradable polymer sirolimus-eluting or durable polymer zotarolimus-eluting stents in high bleeding-risk patients with acute coronary syndrome: the BIOFLOW-DAPT randomized trial.
PMID 42555546 — stents, hemorrhage, polymers, cardiovascular diseases, sirolimus, acute coronary syndrome		Eur Heart J Acute Cardiovasc Care20260

Clinical Studies 40

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 4 Study Chair: 1 Study Director: 2

By phase:

Phase 3 14
N/A 13
Phase 4 9
Phase 2/Phase 3 2
Phase 1 1
Phase 2 1

By status:

Completed 26
Recruiting 6
Active not recruiting 3
Unknown 3
Terminated 2

By type:

Interventional 35
Observational 5

By Monocentric/Multicentric:

monocentric 21
multicentric2to4 5
multicentric5to9 2
multicentricup10 12

Main Topics

Cohort/Consortium Investigators 5

Ongoing Clinical Trials

6 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
A Trial to Test How AZD0780 Affects Serious Heart Stroke or Vascular Problems in Patients with Heart Stroke or Vascular Disease or at High Risk for Such Issues
2025-520519-14-00 — stroke, heart, cardiovascular diseases, vascular diseases		Phase 3Recruiting2025
Safety and efficacy of very short dual antiplatelet therapy followed by P2Y12 inhibitor monotherapy in older patients undergoing percutaneous coronary intervention
2023-507545-28-00 — stents, safety, drug-eluting stents, pharmaceutical preparations, percutaneous coronary intervention, aged, therapeutics		Phase 4Recruiting2026
The Fourth Left Atrial Appendage Occlusion Study
NCT05963698 — atrial appendage, embolism, ischemic stroke, stroke, atrial fibrillation		N/ARecruiting2023
Modalities And Safety Of Cardiac Rehabilitation In A Population Managed For Spontaneous Hematoma Or Coronary Disruption
NCT05744947 — safety, hematoma, cardiac rehabilitation, data collection, rehabilitation, arteries, dissection		N/ARecruiting2023
Assessment of Flecainide to Lower the Patent Foramen Ovale Closure Risk of Atrial Arrhythmia or Tachycardia
NCT05213104 — foramen ovale, patent, ischemic stroke, stroke, arrhythmias, cardiac, acetates, atrial fibrillation, tachycardia, flecainide, foramen ovale		Phase 3Active not recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS